Mass firings and forced resignations swept through the FDA on Tuesday, as part of thousands of planned job cuts at federal ...

The size and scope of the FDA that began Tuesday won’t be the same as the day nears a brutal conclusion for agency staffers ...

Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded ...

The European Medicines Agency is looking to simplify the way it approves biosimilars by removing the need for “extensive” ...

Zus Health, led by former athenahealth CEO Jonathan Bush, aims to create unified health records. Company has 60+ customers ...

GUBamy, AbbVie-licensed amylin drug from Gubra, shows 7.8% weight loss in Phase 1 trial, vs 2% weight gain with placebo after ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

Step back from the multitude of details that go into every big pharma pipeline, and you'll see the influence that ...

Talkspace is using AI to make mini podcast episodes from patients’ therapy sessions. The “Talkcast” episodes are meant to be ...

The FDA overstepped its authority when it issued a rule last May to bring laboratory-developed tests under the agency’s ...

When the transatlantic startup AIRNA launched in 2023, it was already years behind other companies that were trying to bring ...

Eli Lilly's RNA drug solbinsiran reduced ApoB protein levels by 14.3% in Phase 2 cholesterol trial, competing with ...